iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/9347164
Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1997 Sep;11(6):501-2.
doi: 10.1155/1997/434989.

Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide

J K Marshall  1 , E J Irvine
Affiliations
Case Reports

Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide

J K Marshall et al. Can J Gastroenterol. 1997 Sep.

Abstract

Erythema nodosum is a common extraintestinal manifestation of Crohn's disease. While mild skin involvement often responds to conservative management, severe or refractory cases may require systemic corticosteroid or immunosuppressive therapy. This report describes successful treatment of severe, refractory erythema nodosum associated with Crohn's colitis using oral potassium iodide. While the mechanism of action of this agent is poorly understood, it appears to be an effective and nontoxic therapy for Crohn's-related erythema nodosum and warrants further evaluation in a placebo controlled trial.

PubMed Disclaimer

Similar articles

See all similar articles

Publication types

Substances

LinkOut - more resources